AI driven BiCyclic Peptide Design
Our platform represents a paradigm shift in biotherapeutics, moving from static drug delivery to Dynamic, Environment-Responsive Intervention.
We leverage AI models to navigate the complex chemical space of multi-cyclic structures, identifying the most stable and effective molecular architectures.
Conventional peptides often suffer from instability. Our AI driven design platform calculates the optimal Structural Constraint of cyclic scaffolds to ensure extreme metabolic stability and "Lock-and-Key" binding precision. This allows our molecules to remain intact until they reach their intended cellular destination.
The hallmark of our technology is the Autonomous Activation Switch. Through AI-simulated molecular dynamics, we program our molecules to respond to specific chemical signatures within the cellular microenvironment.
Passive State: The molecule remains in a "Masked," inactive form during systemic circulation, ensuring a superior safety profile.
Active State: Upon encountering specific pathological triggers , the molecule undergoes a conformational change to initiate its restorative function.
Strategic Advantages of the Platform
Exceptional Bioavailability: The AI-optimized cyclic architecture is inherently resistant to enzymatic degradation, making it ideal for diverse administration routes.
Smart Selectivity: By programming the molecule to react only to specific environmental cues, we minimize off-target interactions and maximize therapeutic efficiency.
Accelerated R&D Pipeline: Our In-silico-First approach reduces the need for extensive wet-lab trial and error, shortening the lead optimization phase.
Our mission is to deploy intelligent molecular machines that safeguard the fundamental building blocks of life.